Gagnon Advisors, LLC Care Dx, Inc. Transaction History
Gagnon Advisors, LLC
- $137 Million
- Q2 2025
A detailed history of Gagnon Advisors, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Gagnon Advisors, LLC holds 454,163 shares of CDNA stock, worth $5.83 Million. This represents 6.47% of its overall portfolio holdings.
Number of Shares
454,163
Previous 412,875
10.0%
Holding current value
$5.83 Million
Previous $7.33 Million
21.1%
% of portfolio
6.47%
Previous 5.88%
Shares
17 transactions
Others Institutions Holding CDNA
# of Institutions
233Shares Held
57MCall Options Held
51.2KPut Options Held
46K-
Black Rock Inc. New York, NY5.29MShares$67.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.83MShares$62.1 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.67MShares$34.3 Million0.01% of portfolio
-
State Street Corp Boston, MA2.48MShares$31.9 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.35MShares$30.1 Million0.45% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $686M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...